Cover 2 Resources

Cover 2 Resources

Cover 2 Resources

  • Ep. 231 - Part 3; Diversion Out of Control: Joe Rannazzisi Shares What Went Wrong

Ep. 231 - Part 3; Diversion Out of Control: Joe Rannazzisi Shares What Went Wrong

Friday 8th March 2019

Joseph Rannazzisi reveals how DEA's ties with the pharmaceutical industry weakened enforcement against opioids. Listen now on Cover2 Resources.
29 minutes
Informative
Eye-opening
Thought-provoking
Raw
Engaging

About this podcast

Cover 2 Resources
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Inside the DEA: Joseph Rannazzisi Reveals Shocking Industry Influence

Those letters speak for themselves and you could take whatever you want to take away from. And that's basically what those letters said.
Ever wondered how the lines between government and industry get so blurred? In this episode of Cover2 Resources, former DEA official Joseph Rannazzisi pulls back the curtain on how the agency's enforcement approach took a nosedive when key members jumped ship to work for the pharmaceutical industry.
Rannazzisi doesn't hold back as he recounts the passage of the Ensuring Patient Access and Effective Enforcement Act, a law he argues was a 'gift to the industry' rather than a tool for public health. Joined by award-winning author Chris McGreal, who penned 'American Overdose', the discussion dives deep into the murky waters of corporate greed and government complacency.
McGreal's book paints a vivid picture of how corruption and indifference have fueled the opioid crisis, making this episode a must-listen for anyone seeking to understand the systemic failures that have led to one of the worst health crises in American history. Whether you're personally affected by addiction or simply want to grasp the bigger picture, this episode offers eye-opening insights and calls for greater accountability and transparency in tackling the opioid epidemic.